Immunopharmacology: anti-inflammatory therapy targeting transcription factors

Citation
J. Pfeilschifter et H. Muhl, Immunopharmacology: anti-inflammatory therapy targeting transcription factors, EUR J PHARM, 375(1-3), 1999, pp. 237-245
Citations number
99
Categorie Soggetti
Pharmacology & Toxicology
Journal title
EUROPEAN JOURNAL OF PHARMACOLOGY
ISSN journal
00142999 → ACNP
Volume
375
Issue
1-3
Year of publication
1999
Pages
237 - 245
Database
ISI
SICI code
0014-2999(19990630)375:1-3<237:IATTTF>2.0.ZU;2-G
Abstract
Immunopharmacology is one of the most dynamic areas in pharmacology encompa ssing classical immunosuppressive drugs which reveal completely new clues c oncerning their mode of action as well as novel molecular biology approache s for treating inflammatory and autoimmune diseases, infections and cancer. This article focuses on transcription factors that regulate cell activitie s involved in immune and inflammatory cell responses and how traditional an ti-inflammatory compounds such as glucocorticoids, cyclosporins, tacrolismu s and salicylates interfere with the activation cascades triggering the tra nscription factors. Moreover, promising new initiatives for selective thera peutics including recombinant anti-inflammatory cytokines and proinflammato ry cytokine antagonists, and gene therapy will be presented. (C) 1999 Elsev ier Science B.V. All rights reserved.